Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe
Cytek Biosciences, Inc. (CTKB)
Company Research
Source: GlobeNewswire
FREMONT, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, continues its commitment to advancing the cell analysis market by actively participating in key industry gatherings worldwide. The company's Full Spectrum Profiling™ (FSP™) technology, designed for streamlining workflows, expediting discoveries, and enhancing efficiency, will be prominently featured at both CYTO 2024 and AAI’s IMMUNOLOGY2024. The company's distinctive approach to spectral flow cytometry is renowned for its profound influence on advancing the understanding of cell biology, immunology, immunotherapy, oncology and targeted therapeutic methodologies. IMMUNOLOGY2024May 3, 2024 – May 7, 2024Chicago, ILBooth #755The American Association of Immunologists’ (AAI) 107th annual meeting will bring leading researchers together to explore the latest developments in the field of immunology. Cytek will be on hand to showcase its complete cell a
Show less
Read more
Impact Snapshot
Event Time:
CTKB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTKB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTKB alerts
High impacting Cytek Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
CTKB
News
- Cytek Biosciences, Inc. (NASDAQ:CTKB) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Cytek Biosciences, Inc. (NASDAQ: CTKB) had its price target lowered by analysts at Piper Sandler from $10.00 to $8.50. They now have an "overweight" rating on the stock.MarketBeat
- Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Tops Revenue Estimates [Yahoo! Finance]Yahoo! Finance
- Cytek Biosciences Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Cytek Biosciences Reports First Quarter 2024 Financial ResultsGlobeNewswire
CTKB
Earnings
- 5/8/24 - Miss
CTKB
Sec Filings
- 5/8/24 - Form 10-Q
- 5/8/24 - Form 8-K
- 4/25/24 - Form ARS
- CTKB's page on the SEC website